Gastroenterology Medicine - FOI Response Register

I have a freedom of information query regarding the use of Biologic medicines in gastroenterology. Could you please answer the following question:

1. How many patients were treated in the last 3 months by the Gastroenterology department (for any medical condition) with the following biologic drugs:

• Adalimumab – Humira                     <5
• Adalimumab Biosimilar                    18
• Etrasimod                                           0
• Filgotinib                                            0
• Golimumab                                        0
• Infliximab – Remicade                     0
• Infliximab Biosimilar             <5
• Mirikizumab                                       0
• Ozanimod                                          0
• Risankizumab                                   0
• Tofacitinib                                          0
• Upadacitinib                                      <5
• Ustekinumab                         <5
• Vedolizumab                         <5

Where we have given <5 answers this is because NHS Shetland considers that providing more specific detail carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.